These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 34318326

  • 1. Mixed Amphetamine Salts Without a Mood Stabilizer for Treating Comorbid Attention-Deficit Hyperactivity Disorder and Bipolar Disorder: Two Case Reports.
    Armstrong C, Kapolowicz MR.
    Mil Med; 2023 May 16; 188(5-6):e1316-e1319. PubMed ID: 34318326
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder.
    Perugi G, Vannucchi G.
    Expert Opin Pharmacother; 2015 May 16; 16(14):2193-204. PubMed ID: 26364896
    [Abstract] [Full Text] [Related]

  • 4. Differential diagnosis, comorbidity, and treatment of attention-deficit/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults.
    Asherson P, Young AH, Eich-Höchli D, Moran P, Porsdal V, Deberdt W.
    Curr Med Res Opin; 2014 Aug 16; 30(8):1657-72. PubMed ID: 24804976
    [Abstract] [Full Text] [Related]

  • 5. Recognizing and managing bipolar disorder in children.
    Wozniak J.
    J Clin Psychiatry; 2005 Aug 16; 66 Suppl 1():18-23. PubMed ID: 15693748
    [Abstract] [Full Text] [Related]

  • 6. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder.
    Bond DJ, Hadjipavlou G, Lam RW, McIntyre RS, Beaulieu S, Schaffer A, Weiss M, Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force.
    Ann Clin Psychiatry; 2012 Feb 16; 24(1):23-37. PubMed ID: 22303520
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force.
    Miskowiak KW, Obel ZK, Guglielmo R, Bonnin CDM, Bowie CR, Balanzá-Martínez V, Burdick KE, Carvalho AF, Dols A, Douglas K, Gallagher P, Kessing LV, Lafer B, Lewandowski KE, López-Jaramillo C, Martinez-Aran A, McIntyre RS, Porter RJ, Purdon SE, Schaffer A, Stokes PRA, Sumiyoshi T, Torres IJ, Van Rheenen TE, Yatham LN, Young AH, Vieta E, Hasler G.
    Bipolar Disord; 2024 May 16; 26(3):216-239. PubMed ID: 38433530
    [Abstract] [Full Text] [Related]

  • 8. ADHD with Comorbid Bipolar Disorders: A Systematic Review of Neurobiological, Clinical and Pharmacological Aspects Across the Lifespan.
    Mucci F, Avella MT, Marazziti D.
    Curr Med Chem; 2019 May 16; 26(38):6942-6969. PubMed ID: 31385763
    [Abstract] [Full Text] [Related]

  • 9. A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder.
    Mattingly G, Arnold V, Yan B, Yu M, Robertson B.
    J Child Adolesc Psychopharmacol; 2020 Nov 16; 30(9):549-557. PubMed ID: 33185468
    [Abstract] [Full Text] [Related]

  • 10. Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD).
    Perugi G, Pallucchini A, Rizzato S, Pinzone V, De Rossi P.
    Expert Opin Pharmacother; 2019 Aug 16; 20(12):1457-1470. PubMed ID: 31112441
    [Abstract] [Full Text] [Related]

  • 11. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
    Levin FR, Mariani JJ, Specker S, Mooney M, Mahony A, Brooks DJ, Babb D, Bai Y, Eberly LE, Nunes EV, Grabowski J.
    JAMA Psychiatry; 2015 Jun 16; 72(6):593-602. PubMed ID: 25887096
    [Abstract] [Full Text] [Related]

  • 12. Post-Hoc Analyses of the Effects of Baseline Sleep Quality on SHP465 Mixed Amphetamine Salts Extended-Release Treatment Response in Adults with Attention-Deficit/Hyperactivity Disorder.
    Surman CBH, Robertson B, Chen J, Cortese S.
    CNS Drugs; 2019 Jul 16; 33(7):695-706. PubMed ID: 31228031
    [Abstract] [Full Text] [Related]

  • 13. Attention-deficit hyperactivity disorder -- bipolar comorbidity in children and adolescents.
    Masi G, Perugi G, Toni C, Millepiedi S, Mucci M, Bertini N, Pfanner C.
    Bipolar Disord; 2006 Aug 16; 8(4):373-81. PubMed ID: 16879138
    [Abstract] [Full Text] [Related]

  • 14. Psychotic disorders comorbid with attention-deficit hyperactivity disorder: an important knowledge gap.
    Levy E, Traicu A, Iyer S, Malla A, Joober R.
    Can J Psychiatry; 2015 Mar 16; 60(3 Suppl 2):S48-52. PubMed ID: 25886680
    [Abstract] [Full Text] [Related]

  • 15. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
    Wiesegger G, Kienbacher C, Pellegrini E, Scheidinger H, Vesely C, Bangerl W, Friedrich M.
    Neuropsychiatr; 2007 Mar 16; 21(3):187-206. PubMed ID: 17915180
    [Abstract] [Full Text] [Related]

  • 16. A systematic review of pharmacotherapy for attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders.
    Pouchon A, Nasserdine R, Dondé C, Bertrand A, Polosan M, Bioulac S.
    Expert Opin Pharmacother; 2023 Mar 16; 24(13):1497-1509. PubMed ID: 37300473
    [Abstract] [Full Text] [Related]

  • 17. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
    Nierenberg AA, Miyahara S, Spencer T, Wisniewski SR, Otto MW, Simon N, Pollack MH, Ostacher MJ, Yan L, Siegel R, Sachs GS, STEP-BD Investigators.
    Biol Psychiatry; 2005 Jun 01; 57(11):1467-73. PubMed ID: 15950022
    [Abstract] [Full Text] [Related]

  • 18. [Adult ADHD: clinical aspects and therapeutic implications].
    Ceraudo G, Vannucchi G, Perugi G, Dell'osso L.
    Riv Psichiatr; 2012 Jun 01; 47(6):451-64. PubMed ID: 23160106
    [Abstract] [Full Text] [Related]

  • 19. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.
    Gillberg C, Melander H, von Knorring AL, Janols LO, Thernlund G, Hägglöf B, Eidevall-Wallin L, Gustafsson P, Kopp S.
    Arch Gen Psychiatry; 1997 Sep 01; 54(9):857-64. PubMed ID: 9294377
    [Abstract] [Full Text] [Related]

  • 20. ADHD and Bipolar Disorder in Adulthood: Clinical and Treatment Implications.
    Salvi V, Ribuoli E, Servasi M, Orsolini L, Volpe U.
    Medicina (Kaunas); 2021 May 10; 57(5):. PubMed ID: 34068605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.